Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Eledon Pharmaceuticals Inc (NASDAQ: ELDN)

 
ELDN Technical Analysis
5
As on 9th Jun 2023 ELDN STOCK Price closed @ 1.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.27 & Strong Sell for SHORT-TERM with Stoploss of 4.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ELDNSTOCK Price

Open 1.94 Change Price %
High 2.08 1 Day 0.00 0.00
Low 1.81 1 Week -0.20 -9.52
Close 1.90 1 Month -0.28 -12.84
Volume 120337 1 Year -2.58 -57.59
52 Week High 4.89 | 52 Week Low 1.75
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ELDN
Daily Charts		 ELDN
Intraday Charts		 Whats New @
Bazaartrend		 ELDN
Free Analysis
 
ELDN Important Levels Intraday
RESISTANCE2.42
RESISTANCE2.25
RESISTANCE2.15
RESISTANCE2.05
SUPPORT1.75
SUPPORT1.65
SUPPORT1.55
SUPPORT1.38
 
ELDN Forecast May 2024
Share
4th UP Forecast5.33
3rd UP Forecast4.23
2nd UP Forecast3.55
1st UP Forecast2.87
1st DOWN Forecast0.93
2nd DOWN Forecast0.25
3rd DOWN Forecast-0.43
4th DOWN Forecast-1.53
 
ELDN Weekly Forecast
4th UP Forecast3.73
3rd UP Forecast3.14
2nd UP Forecast2.78
1st UP Forecast2.42
1st DOWN Forecast1.38
2nd DOWN Forecast1.02
3rd DOWN Forecast0.66
4th DOWN Forecast0.07
 
ELDN Forecast2024
4th UP Forecast8.63
3rd UP Forecast6.47
2nd UP Forecast5.14
1st UP Forecast3.8
1st DOWN Forecast0
2nd DOWN Forecast-1.34
3rd DOWN Forecast-2.67
4th DOWN Forecast-4.83
 
 
ELDN Other Details
Segment EQ
Market Capital 70354136.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ELDN Address
ELDN
 
ELDN Latest News
 
Your Comments and Response on Eledon Pharmaceuticals Inc
 
ELDN Business Profile
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. Eledon Pharmaceuticals, Inc. has a collaboration agreement with CareDx, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Address: 19900 MacArthur Boulevard, Irvine, CA, United States, 92612
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service